UK launches new payment model for antimicr...In order to incentivise drug companies to re-enter development of antibiotics, the UK government announced it will establish a licence model to assure developers sufficient return on investments (RO … more ➔
BioNtech swallows MAB Discovery antibody u...Immunoncology and vaccine specialist BioNTech AG is broadening its antibody discovery capabilities by acquiring MAB Discoverys antibody generation unit. more ➔
Clariant inks cellulosic biodiesel pact wi...Swiss fine chemicals specialist Clariant has hammered out a R&D pact with ExxonMobil and Renewable Energy Group (REG) Inc to combine technologies in order of producing biodiesel from cellulose&n … more ➔
IMI launches €80m callThe Innovative Medicines Initiative II has earmarked €80m for pre-competetive research improving the pharmaceutical industry’s productivity. more ➔
AMR: Novo Holdings funds companies with ...Novo Holdings has invested €18m from its €135m REPAIR Impact Fund into four companies. more ➔
Boehringer expands neurology activitiesBoehringer Ingelheim has expanded its 2014 R&D collaboration with the BioMed X Innovation Center (Heidelberg, Germany) to find new treatment approaches for early intervention of psychiatric dise … more ➔
New target for lung fibrosis discoveredCanadian and Finnish researchers have demonstrated that long immune cell contact to lung tissue turns tissue repair into fibrosis. more ➔
Valneva inks $59m JE vaccine supply contra...French vaccine specialist Valneva SE has inked a supply contract with the US Department of Defense for IXIARO its Japanese encephalitis (JE). more ➔
VTT turn waste into biofuels and chemicalsResearchers at VTT Technical Research Centre of Finland Ltd have presented a new gasification-based technique to turn forest industry byproducts into transport fuels and chemicals. more ➔
Tissue specific tumour transition needs fe...German researchers have modeled when cellular alterations inevitably lead to the development of cancer. The transition is tissue-specific and needs only a few cells. more ➔
